Archives
Mitochondrial NAD+ Deficiency Drives Aortic Aneurysm via ECM
2026-06-02
Mitochondrial NAD+ Deficiency Drives Aortic Aneurysm via ECM Disruption
Study Background and Research Question
Degenerative changes in the vascular extracellular matrix (ECM) are central to the pathogenesis of aortic aneurysms and dissections, conditions associated with high mortality due to the risk of catastrophic rupture. While several genetic and mechanobiological factors have been implicated in the balance of collagen synthesis and degradation, much of the molecular etiology underlying thoracic and abdominal aortic aneurysm (TAAA) remains unresolved. The reference study (Nature Cardiovascular Research, 2025) specifically investigated whether mitochondrial metabolism—particularly the cellular NAD+ pool—regulates ECM homeostasis and thereby contributes to aortic disease development.Key Innovation from the Reference Study
The central innovation of the study is the demonstration that mitochondrial NAD+ deficiency in vascular smooth muscle cells (VSMCs) is a causal factor for aortic aneurysm formation, acting through impaired turnover of type III collagen. Multiomics profiling and genetic models show that disruption of the NAD+ pool, via impaired salvage and mitochondrial transport pathways, leads to defective proline biosynthesis. Since proline is an essential amino acid for collagen synthesis, this deficiency directly impairs the production and maintenance of collagen III, ultimately compromising the structural integrity of the aortic wall. These findings bridge previously disconnected domains of mitochondrial metabolism and ECM regulation, offering a new mechanistic understanding of aneurysm pathogenesis.Methods and Experimental Design Insights
The study utilized a comprehensive multiomics approach, including proteomic, transcriptomic, and metabolomic profiling of human thoracic aortic specimens at various disease stages. In total, 113 samples from patients undergoing ascending aortic replacement and 37 non-diseased controls were analyzed, ensuring age-matched comparisons. The proteomics workflow generated a spectral library encompassing over 10,000 proteins, including 908 mitochondrial proteins, to enable in-depth characterization of disease-associated changes. To establish causality, the authors generated mouse models with smooth muscle-specific knockouts of key NAD+ salvage and transport genes (Nampt, Nmnat1/3, Slc25a51, Nadk2, and Aldh18a1). Of these, Slc25a51 deletion produced the most severe aortic aneurysm phenotype, highlighting the critical role of mitochondrial NAD+ import. The study also incorporated genome-wide gene-based association analyses to link human SLC25A51 expression variants with aneurysm risk, further supporting the translational relevance of the findings.Core Findings and Why They Matter
Multiomics analysis revealed a significant impairment in NAD+ salvage and mitochondrial NAD+ transport in human thoracic aortic aneurysm samples, with SLC25A51 expression inversely correlating with disease severity and postoperative progression (reference study). Genome-wide association data indicated that individuals with lower SLC25A51 expression are at increased risk for aortic aneurysm and dissection. In murine models, knockout of genes involved in the NAD+ salvage pathway and mitochondrial NAD+ import resulted in the development of aortic aneurysms, with pronounced effects following Slc25a51 deletion. Mechanistically, the study identified that mitochondrial NAD+ deficiency disrupts proline biosynthesis in VSMCs. Since type III collagen synthesis during aortic medial matrix turnover imposes a high demand for proline, this metabolic bottleneck leads to a failure in collagen III maintenance and turnover, thus predisposing the aortic wall to dilation and rupture. This work substantially extends the understanding of ECM homeostasis by demonstrating that metabolic cues from mitochondria directly inform collagen biosynthetic capacity, providing a tangible link between energy metabolism and vascular structural integrity.Comparison with Existing Internal Articles
Recent internal reviews, such as "Mitochondrial NAD+ Deficiency Drives Aortic Aneurysm via Collagen III Disruption", have summarized the mechanistic link between mitochondrial NAD+ metabolism and ECM disruption in aneurysm formation, closely paralleling the findings of the reference study. Additional workflow-oriented guides, including "Zoledronic Acid: Protocols and Solutions for ECM and Cancer Research", provide practical insight into investigating ECM remodeling and apoptosis in vascular and cancer models. These resources underscore the growing emphasis on multiomics and metabolic profiling as key tools for unraveling ECM-related pathologies and for developing precision protocols utilizing agents such as nitrogen-containing bisphosphonates in translational research.Limitations and Transferability
While the reference study leverages high-dimensional -omics data and robust genetic models to establish causality, some limitations remain. The majority of mechanistic validation was performed in murine models, and while human tissue profiling substantiates the metabolic signature, additional direct functional studies in human VSMCs would strengthen translational claims. Moreover, while the link between NAD+ deficiency and proline/collagen biosynthesis is compelling, the broader implications for other ECM proteins or cell types in the vascular wall remain to be elucidated. Transferability to other forms of vascular remodeling or to related diseases such as atherosclerosis will require targeted investigation.Protocol Parameters
- Sample stratification: Use clearly defined disease stages for multiomics profiling (e.g., nondiseased, moderate, severe, acute dissection).
- Proteomics workflow: Generate a spectral library encompassing >10,000 proteins, including mitochondrial subsets, for comprehensive ECM and metabolic profiling.
- Genetic modeling: Employ smooth muscle-specific knockout of NAD+ salvage/transport genes (e.g., Slc25a51) in mice to establish causality in ECM turnover and aneurysm formation.
- Metabolomic analysis: Quantify proline and NAD+ metabolites in aortic tissue to directly assess the metabolic bottleneck in collagen III synthesis.
- Histological validation: Correlate molecular findings with collagen III content and medial degeneration using immunostaining and morphometric analysis.
- Gene association analysis: Integrate genome-wide association study data to link genetic variation in NAD+ transporter expression with clinical risk.